New Board Member
Magnus Nilsson has been appointed new Board Member in Immunicum AB (publ). He succeeds Alex Karlsson-Parra and Per-Olof Gunnesson who will continue their work in the management group.
About Magnus Nilsson
Born 1956, Doctor Med. Sc. at Uppsala Universitet. CEO in Xvivo Perfusion from 2011 and before that CEO in Vitrolife since 2003. Before that project leader for preclinical and clinical development, KaroBio AB and Pharmacia & Upjohn AB.
Notice: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4805